The case for 'successfully' treating hormone naive metastatic prostate cancer

被引：0
|
作者：
Efstathiou, E. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷 / 05期
关键词：
D O I：
10.1093/annonc/mdy122
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1084 / 1086
页数：4
相关论文
共 50 条
  • [21] Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer: Comparing definitions of CHAARTED and LATITUDE trial
    Buelens, Sarah
    Poelaert, Filip
    Dhondt, Bert
    Fonteyne, Valerie
    De Visschere, Pieter
    Ost, Piet
    Verbeke, Sofie
    Villeirs, Geert
    De Man, Kathia
    Rottey, Sylvie
    Decaestecker, Karel
    Lumen, Nicolaas
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (04) : 158.e13 - 158.e20
  • [22] FIRST ORAL HORMONE FOR TREATING PROSTATE CANCER
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2021, 121 (04) : 22 - 23
  • [23] Nanodiamonds enhance therapeutic efficacy of doxorubicin in treating metastatic hormone-refractory prostate cancer
    Salaam, Amanee D.
    Hwang, Patrick T. J.
    Poonawalla, Aliza
    Green, Hadiyah N.
    Jun, Ho-wook
    Dean, Derrick
    NANOTECHNOLOGY, 2014, 25 (42)
  • [24] Treatment of Castration-naive Metastatic Prostate Cancer
    Hamilou, Zineb
    Baciarello, Giulia
    Fizazi, Karim
    EUROPEAN UROLOGY FOCUS, 2017, 3 (06): : 518 - 521
  • [25] CYTOREDUCTIVE RADICAL PROSTATECTOMY (CRP) IS FEASIBLE IN MEN WITH HORMONE-NAIVE, METASTATIC PROSTATE CANCER (MPCA).
    Heidenreich, Axel
    Karnes, Jeff. R.
    Briganti, Alberto
    Shariat, Shahrokh
    Porres, Daniel
    Fossati, Nicola
    Montorsi, Francesco
    Suardi, Nazareno
    Pfister, David
    JOURNAL OF UROLOGY, 2017, 197 (04): : E721 - E721
  • [26] Chemotherapy in metastatic hormone-naive prostate cancer: Pooled analysis of randomized clinical trials.
    Fabbri, Paolo
    Stocchi, Lucia
    Nicoletti, Stefania
    Drudi, Fabrizio
    Tamburini, Emiliano
    Nicolini, Mario
    Gianni, Lorenzo
    Pasini, Giuseppe
    Montanari, Francesco
    Tassinari, Davide
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [27] Trends in the use of local intervention for metastatic hormone-naive prostate cancer: A multicenter retrospective study
    Tanaka, Ryuma
    Hatakeyama, Shingo
    Narita, Shintaro
    Sakurai, Toshihiko
    Tanaka, Toshikazu
    Miura, Hikari
    Oishi, Takuya
    Kawamura, Sadafumi
    Hoshi, Senji
    Ishidoya, Shigeto
    Mitsuzuka, Koji
    Ito, Akihiro
    Tsuchiya, Norihiko
    Habuchi, Tomonori
    Ohyama, Chikara
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (11) : 969 - 976
  • [28] In Hormone-Naive Metastatic Prostate Cancer, Should All Patients Now Receive Docetaxel? No, Not Yet
    Armstrong, Andrew J.
    ONCOLOGY-NEW YORK, 2014, 28 (10): : 881 - +
  • [29] TRPM8 protein expression in hormone naive local and lymph node metastatic prostate cancer
    Lunardi, Andrea
    Barbareschi, Mattia
    Carbone, Francesco Giuseppe
    Morelli, Luca
    Brunelli, Matteo
    Fortuna, Nicolo
    Genovesi, Sacha
    Alaimo, Alessandro
    PATHOLOGICA, 2021, 113 (02) : 95 - 101
  • [30] A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naive Metastatic Prostate Cancer
    Corn, Paul G.
    Zhang, Miao
    Nogueras-Gonzalez, Graciela M.
    Xiao, Lianchun
    Zurita, Amado J.
    Subudhi, Sumit K.
    Tu, Shi-Ming
    Aparicio, Ana M.
    Coarfa, Cristian
    Rajapakshe, Kimal
    Huang, Shixia
    Navone, Nora M.
    Lin, Sue-Hwa
    Wang, Guocan
    Ramachandran, Sumankalai
    Titus, Mark A.
    Panaretakis, Theocharis
    Gallick, Gary E.
    Efstathiou, Eleni
    Troncoso, Patricia
    Logothetis, Christopher
    CLINICAL CANCER RESEARCH, 2020, 26 (05) : 990 - 999
12345